Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (11-20 of 608) with videos related to

Pageof 61
Sort By:
Seminars in Thrombosis and Hemostasis|February 24, 2015
Treatment of hemophilia in the near futureFlora Peyvandi, Isabella Garagiola
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP<sup>®</sup>Omid Seidizadeh, Flora Peyvandi
The New England Journal of Medicine|June 23, 2016
Caplacizumab for Acquired Thrombotic Thrombocytopenic PurpuraFlora Peyvandi, Filip Callewaert
Blood Transfusion = Trasfusione Del Sangue|January 1, 2009
National and international registries of rare bleeding disordersFlora Peyvandi, Marta Spreafico
Seminars in Thrombosis and Hemostasis|July 15, 2009
Combined Factor V and Factor VIII DeficiencyMarta Spreafico, Flora Peyvandi
Blood|August 16, 2020
How I treat thrombotic thrombocytopenic purpura in pregnancyBarbara Ferrari, Flora Peyvandi
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 9, 2019
Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophiliaFlora Peyvandi, Isabella Garagiola
Seminars in Thrombosis and Hemostasis|July 15, 2009
Factor V deficiencyRosanna Asselta, Flora Peyvandi
Seminars in Thrombosis and Hemostasis|August 29, 2024
Clinical, Laboratory Aspects and Management of Factor X DeficiencyMarzia Menegatti, Flora Peyvandi
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Product type and other environmental risk factors for inhibitor development in severe hemophilia AFlora Peyvandi, Isabella Garagiola
Pageof 61

Showing results (11-20 of 608) with videos related to

Sort By:
Pageof 61
Seminars in Thrombosis and Hemostasis|February 24, 2015
Treatment of hemophilia in the near futureFlora Peyvandi, Isabella Garagiola
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Laboratory Testing for von Willebrand Factor Activity by a Glycoprotein Ib-Binding Assay (VWF:GPIbR): HemosIL von Willebrand Factor Ristocetin Cofactor Activity on ACL TOP<sup>®</sup>Omid Seidizadeh, Flora Peyvandi
The New England Journal of Medicine|June 23, 2016
Caplacizumab for Acquired Thrombotic Thrombocytopenic PurpuraFlora Peyvandi, Filip Callewaert
Blood Transfusion = Trasfusione Del Sangue|January 1, 2009
National and international registries of rare bleeding disordersFlora Peyvandi, Marta Spreafico
Seminars in Thrombosis and Hemostasis|July 15, 2009
Combined Factor V and Factor VIII DeficiencyMarta Spreafico, Flora Peyvandi
Blood|August 16, 2020
How I treat thrombotic thrombocytopenic purpura in pregnancyBarbara Ferrari, Flora Peyvandi
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 9, 2019
Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophiliaFlora Peyvandi, Isabella Garagiola
Seminars in Thrombosis and Hemostasis|July 15, 2009
Factor V deficiencyRosanna Asselta, Flora Peyvandi
Seminars in Thrombosis and Hemostasis|August 29, 2024
Clinical, Laboratory Aspects and Management of Factor X DeficiencyMarzia Menegatti, Flora Peyvandi
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Product type and other environmental risk factors for inhibitor development in severe hemophilia AFlora Peyvandi, Isabella Garagiola
Pageof 61